St. Judes wins CE Mark for next-gen heart defibrillators

05/13/2013 | MedGadget.com

St. Jude Medical received the CE mark for its Ellipse and SJM Assura suite of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The next-generation devices are used to administer high-voltage electricity to heart tissue and come with advanced coating to help lower the risk for electrode lead abrasion.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY